# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000912282-15-000380
Filing Date
2015-09-30
Accepted
2015-09-30 12:11:55
Documents
32
Period of Report
2015-09-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | antriabio8k_09292015.htm | 8-K | 26596
2 | INVESTOR PRESENTATION | ex99_1.htm | EX-99.1 | 27166
3 |  | slide1.jpg | GRAPHIC | 25366
4 |  | slide2.jpg | GRAPHIC | 187288
5 |  | slide3.jpg | GRAPHIC | 87406
6 |  | slide4.jpg | GRAPHIC | 53260
7 |  | slide5.jpg | GRAPHIC | 101495
8 |  | slide6.jpg | GRAPHIC | 24328
9 |  | slide7.jpg | GRAPHIC | 108678
10 |  | slide8.jpg | GRAPHIC | 107426
11 |  | slide9.jpg | GRAPHIC | 112321
12 |  | slide10.jpg | GRAPHIC | 123993
13 |  | slide11.jpg | GRAPHIC | 92168
14 |  | slide12.jpg | GRAPHIC | 105144
15 |  | slide13.jpg | GRAPHIC | 98998
16 |  | slide14.jpg | GRAPHIC | 88467
17 |  | slide15.jpg | GRAPHIC | 112906
18 |  | slide16.jpg | GRAPHIC | 109418
19 |  | slide17.jpg | GRAPHIC | 116860
20 |  | slide18.jpg | GRAPHIC | 108413
21 |  | slide19.jpg | GRAPHIC | 104323
22 |  | slide20.jpg | GRAPHIC | 24819
23 |  | slide21.jpg | GRAPHIC | 74969
24 |  | slide22.jpg | GRAPHIC | 96567
25 |  | slide23.jpg | GRAPHIC | 57554
26 |  | slide24.jpg | GRAPHIC | 113207
27 |  | slide25.jpg | GRAPHIC | 91134
28 |  | slide26.jpg | GRAPHIC | 48314
29 |  | slide27.jpg | GRAPHIC | 67017
30 |  | slide28.jpg | GRAPHIC | 147701
31 |  | slide29.jpg | GRAPHIC | 137210
32 |  | slide30.jpg | GRAPHIC | 45685
| Complete submission text file | 0000912282-15-000380.txt |  | 3875870

Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 151133146
SIC: 2834 Pharmaceutical Preparations